Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real‐life data

Reported median overall survival (mOS) in metastatic colorectal cancer (mCRC) patients participating in systemic therapy trials has increased to over 30 months. It is uncertain whether trial results translate to real‐life populations. Moreover, patients prefer presentation of multiple survival scena...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Hamers, Patricia A. H., Elferink, Marloes A. G., Stellato, Rebecca K., Punt, Cornelis J. A., May, Anne M., Koopman, Miriam, Vink, Geraldine R.
Formaat: Online Artikel Texto
Taal:English
Gepubliceerd in: John Wiley & Sons, Inc. 2020
Onderwerpen:
Cancer Epidemiology
Online toegang:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754475/
https://www.ncbi.nlm.nih.gov/pubmed/32638384
http://dx.doi.org/10.1002/ijc.33200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754475/
https://www.ncbi.nlm.nih.gov/pubmed/32638384
http://dx.doi.org/10.1002/ijc.33200

Gelijkaardige items